Journal
CANCER CELL
Volume 23, Issue 6, Pages 718-723Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2013.04.002
Keywords
-
Categories
Funding
- Ministry of Education, Science, Sports and Culture, Japan
- Ministry of Health, Labor and Welfare, Japan
- Grants-in-Aid for Scientific Research [25250017, 22134005, 221S0001] Funding Source: KAKEN
Ask authors/readers for more resources
Emerging evidence indicates that NKX2-1, a homeobox-containing transcription factor also known as TTF-1, plays a role as a lineage-survival oncogene in lung adenocarcinomas. In T cell acute lymphoblastic leukemia, gene rearrangements lead to aberrant expression of NKX2-1/TTF-1. Despite accumulating evidence supporting its oncogenic role, it has become apparent that NKX2-1/TTF-1 expression also has biological and clinical functions in the opposite direction that act against tumor progression. Herein, we review recent findings showing these enigmatic double-edged characteristics, with special attention given to the roles of NKX2-1/TTF-1 in lung development and carcinogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available